Achieve Life Sciences, Inc. Public Float
Achieve Life Sciences, Inc. (ACHV) had Public Float of $103.96 million as of 2025-06-30, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-30
- 2025-06-30: Entity Public Float $103.96M.
- 2024-06-30: Entity Public Float $144.08M.
- 2023-06-30: Entity Public Float $90.76M.
- 2022-06-30: Entity Public Float $47.15M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $103.96M 10-K/A · filed 2026-04-30 |
| 2024-06-30 | $144.08M 10-K · filed 2025-03-11 |
| 2023-06-30 | $90.76M 10-K · filed 2024-03-28 |
| 2022-06-30 | $47.15M 10-K/A · filed 2023-05-16 |
| 2021-06-30 | $84.75M 10-K · filed 2022-03-10 |
| 2020-06-30 | $15.39M 10-K · filed 2021-03-11 |
| 2019-06-30 | $15.10M 10-K · filed 2020-03-13 |
| 2018-06-30 | $15.06M 10-K · filed 2019-03-14 |
| 2017-06-30 | $10.68M 10-K · filed 2018-03-01 |
| 2016-06-30 | $29.65M 10-K · filed 2017-02-23 |
| 2015-06-30 | $48.99M 10-K · filed 2016-03-09 |
| 2014-06-30 | $48.99M 10-K · filed 2015-03-26 |
| 2013-06-29 | $143.87M 10-K · filed 2014-03-11 |
| 2012-06-30 | $163.80M 10-K · filed 2013-03-07 |
| 2011-06-30 | $163.80M 10-K · filed 2012-03-08 |
| 2010-06-30 | $86.06M 10-Q · filed 2011-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |